Introduction {#sec1-2055207619897155}
============

Drugs are one of the most dangerous and commonly used poisonous substances.^[@bibr1-2055207619897155]^ Drug poisoning is the most prevalent type of poisoning worldwide which can occur intentional or unintentional. Unintentional drug poisoning is occurred due to drug interactions, physiological problems in the body such as liver and kidney failure, and misuse by children.^[@bibr2-2055207619897155]^ Intentional drug poisoning is happened due to much consumption of drugs by adults for suicide attempts.^[@bibr3-2055207619897155]^ Typically, drugs that are kept at home, such as sedative pills and analgesics, are the most common cause of poisoning.^[@bibr4-2055207619897155]^ Drug poisoning has occurred when drugs are taken in error, used for suicide and homicide intent, prescribed drugs for someone else are taken, and self-prescribed drugs are taken with over the counter drugs and intoxication. Actually, adverse drug events are happened when prescribed drugs are taken correctly, but an adverse reaction such as an allergic reaction, idiosyncratic reaction, and drug interaction is occurred. Unintentional drug poisoning or toxic effects of drugs could be types of adverse drug events.^[@bibr5-2055207619897155]^

One of the most important causes of emergency department visits in the USA, is drug poisoning.^[@bibr6-2055207619897155],[@bibr7-2055207619897155]^ In Iran, about 70% of poisonings referring to drug information centres are drug poisonings. According to the Iranian Forensic Medicine Organization, nearly 5500 Iranian people die every year due to poisoning, of which 700 deaths are due to drug poisoning.^[@bibr8-2055207619897155]^

Due to the large number of referrals drug poisoning patients to hospitals, recording the patients\' data in order to prevent, control and manage treatment can be very helpful and facilitate evidence-based decision making in health system policies and plans.^[@bibr9-2055207619897155]^ Electronic record of patient health information while having a dynamic and flexible structure provides for data collection and reporting evidence-based, up-to-date and accurate health information.^[@bibr10-2055207619897155]^ Drug poisoning registry systems, as types of health information systems, may facilitate reporting the incidence and prevalence of diseases, temporal and spatial changes, the quality of care assessment, and improve research by collecting, analysing and reporting regularly health information of a specific population.^[@bibr11-2055207619897155]^

Some developed countries such as the USA (Toxicology Investigators Consortium (ToxIC))^[@bibr12-2055207619897155]^ and Australia (Hunter Area Toxicology Service (HATS))^[@bibr13-2055207619897155]^ have constructed their poisoning registry for gathering data about poisoning cases; in addition, The World Health Organization has provided International Toxicology (INTOX) software for data management of poison control centres.^[@bibr14-2055207619897155]^ However, there is no specific drug poisoning registry in Iran and some other countries.

The initial step in managing disease information for quality of care improving and controlling disease, is designing a minimum data set (MDS).^[@bibr15-2055207619897155]^ Development of a MDS, as the core health data element, for gathering data with uniform definitions in a standard way to ensure comparability is very important.^[@bibr16-2055207619897155]^ Using an MDS in a disease registry system is necessary to access reliable and comparable information about the number of patients, therapeutic methods, and outcomes of the provided health services relating to a specific disease.^[@bibr17-2055207619897155]^

Since there is no registry system for drug poisoning in Iran, the design and creation of a MDS, as the first step, is essential for the collection, processing, analysis and reporting of appropriate drug poisoning information in order to maintain and improve the health of the community. The aim of this study was to develop a MDS for drug poisoning registry system in Iran.

Methods {#sec2-2055207619897155}
=======

This study was conducted in three phases including (a) identification of available drug poisoning MDS, (b) questionnaire development, and (c) final version of MDS development, and these phases are presented in the following sections.

Identification of available drug poisoning MDS {#sec3-2055207619897155}
----------------------------------------------

This descriptive and cross-sectional study was conducted in 2019. We aimed to develop a MDS for a drug poisoning registry system. In the first step to retrieve related resources (articles, reports, forms and theses), scientific databases such as the Web of Knowledge, PubMed, Scopus, Google Scholar, SID, MagIran and Google search engine were reviewed by keywords including 'poisoning data\', 'drug poisoning data\', 'drug poisoning registry\', 'poisoning registry form\', 'drug poisoning registry system MDS\', 'minimum data set\', 'data set\', and 'data element from\'. The inclusion criteria were articles, reports, forms and theses in Persian and English languages, published from 2000--2018. Letters to the editor, short communication, articles with no abstract and full text, not specifically related to the poisoning registry and not available MDS were excluded. Data were extracted from the related retrieved resources and entered into the checklist with two administrative and clinical sections. In the second step, the medical records of drug poisoning patients at Afzalipour hospital affiliated to Kerman University of Medical Sciences were assessed and related data were also entered to the checklist.

Questionnaire development {#sec4-2055207619897155}
-------------------------

A questionnaire was developed using the data elements of the checklist and had three columns 'essential\', 'useful, but not essential\', and 'not essential\'. For adding necessary data by experts, a blank row was considered at the end of the questionnaire. The content validity of the questionnaire was assessed by an expert panel including two health information management and two clinical toxicologist experts. Cronbach\'s alpha was used to evaluate the reliability of the questionnaire. The collected data were analysed using SPSS 19, and the Cronbach's alpha value for the entire questionnaire was obtained 0.9; then, the reliability of the questionnaire was confirmed.

Research samples for determination of a MDS for drug poisoning registry system were eight experts of health information management departments of Tehran and Kerman Universities of Medical Sciences, and eight clinical toxicology experts working in Loghman Hakim, Baharloo and Afzalipour Hospitals affiliated to Shahid Beheshti, Tehran, and Kerman Universities of Medical Sciences, respectively. [Table 1](#table1-2055207619897155){ref-type="table"} shows the demographic characteristics of these experts.

###### 

Demographic characteristics of experts who participated to validate the preliminary data elements.

![](10.1177_2055207619897155-table1)

  ------------------------------------------------------------------------------------------------------------------
  Experts                         Number   Sex          Age group    Education degree   Average year of experience
  ------------------------------- -------- ------------ ------------ ------------------ ----------------------------
  Health information management   8        Female: 6\   30--39: 1\   PhD                17.37
                                           Male: 2      40--49: 3\                      
                                                        50--59: 4                       

  Clinical toxicology             8        Female: 3\   30--39: 1\   Fellowship         11.62
                                           Male: 5      40--49: 5\                      
                                                        50--59: 2                       
  ------------------------------------------------------------------------------------------------------------------

The questionnaire was given to the experts and we asked health information management experts to complete the administrative section and clinical toxicologists the clinical section.

Final version of MDS development {#sec5-2055207619897155}
--------------------------------

The questionnaire was analysed using the following formula for Content Validity Ratio (CVR): $$\text{CVR} = \left( {\text{Ne}–\text{N}/\text{2}} \right)/\left( {\text{N}/\text{2}} \right)$$

'Ne' is the number of experts who have chosen the 'essential' option for an element, and 'N' is the total number of experts. In the first step, CVR was calculated for each data element and was compared with the Lawshe table value.^[@bibr18-2055207619897155]^ Additionally, the mean of expert judgments was also calculated for each data element by replacing the number 2 for 'essential\', the number 1 for 'useful, but not essential\', and the number 0 for 'not essential\' in the columns. Each data element that gained a value equal or greater than 0.75 for CVR (considering the number of eight experts) was accepted and used as starred item in the registry system that must be filled. If the value of CVR was between 0 and 0.75 and the mean of judgments was equal and greater than 1.5 for a data element, it was also accepted and used as usual item in the registry system that could be filled. The data elements for which the value of CVR was less than 0 and the mean of judgments was less than 1.5 were refused.

Results {#sec6-2055207619897155}
=======

Identification of available drug poisoning MDS {#sec7-2055207619897155}
----------------------------------------------

Final retrieved resources for the MDS collection phase included ToxIC of USA,^[@bibr12-2055207619897155]^ HATS of Australia,^[@bibr13-2055207619897155]^ Northern Ireland registry of self-harm,^[@bibr19-2055207619897155]^ National Poison Data System (NPDS) of USA,^[@bibr20-2055207619897155]^ National Poisons Information Centers (NPIC) of Australia,^[@bibr21-2055207619897155]^ and INTOX software of the World Health Organization.^[@bibr14-2055207619897155]^ The MDS for developing a drug poisoning registry system was categorised into the administrative and clinical parts. The administrative part has three sections including: demographic information (23 items), presentation information (9 items) and discharge information (6 items) ([Table 2](#table2-2055207619897155){ref-type="table"}). The clinical part has six sections including: diagnostic information (3 items), exposure information (20 items), medical history (17 items), clinical findings (20 items), diagnostic intervention (22 items) and treatment information (6 items) ([Table 3](#table3-2055207619897155){ref-type="table"}). The clinical data were related to control vocabularies of International Classification of Diseases 10th Revision (ICD-10) (T36--T50) and International Classification of Health Interventions (ICHI).

###### 

Administrative minimum data set (MDS) for drug poisoning registry system design.

![](10.1177_2055207619897155-table2)

  Group                      Number                                                                                                                                      Minimum data set                                                                 ToxIC   HATS   Northern Ireland registry   NPDS   NPIC   INTOX   Medical record   CVR    Numerical mean of judgments   Accept or refuse
  -------------------------- ------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ------- ------ --------------------------- ------ ------ ------- ---------------- ------ ----------------------------- ------------------
  Demographic information    1                                                                                                                                           Name                                                                                     ✓                                         ✓              ✓                0.5    1.5                           Accept
  2                          Family name                                                                                                                                                                                                                  ✓                                          ✓             ✓       0.5              1.5    Accept                        
  3                          Father's name                                                                                                                                                                                                                                                                         ✓       0.5              1.5    Accept                        
  4                          Medical record number^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                ✓                                                                                ✓       ✓      ✓                           ✓             ✓       1                2      Accept                        
  5                          Age^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                  ✓                                                                                ✓       ✓      ✓                           ✓      ✓      ✓       1                2      Accept                        
  6                          Sex^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                  ✓                                                                                        ✓      ✓                           ✓      ✓      ✓       1                2      Accept                        
  7                          Ethnicity                                                                                                                                                                                                                    ✓                                                 ✓      ✓       --0.75           0.87   Refuse                        
  8                          Race                                                                                                                                                                                                                                                                           ✓              --1              0.75   Refuse                        
  9                          Marital status^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                        ✓                                                 ✓      ✓       1                2      Accept                        
  10                         Pregnancy status^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                     ✓                                                                                               ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  11                         Lactation status^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                                                                        ✓      ✓       0.75             1.87   Accept                        
  12                         Height                                                                                                                                                                                                                       ✓                                                 ✓              0.25             1.62   Accept                        
  13                         Weight ^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                               ✓                                          ✓      ✓      ✓       0.75             1.87   Accept                        
  14                         City of birth                                                                                                                                                                                                                                                                         ✓       0.25             1.5    Accept                        
  15                         Country of birth                                                                                                                                                                                                             ✓                                                        ✓       0                1.37   Refuse                        
  16                         National code^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                                                                                  ✓       0.75             1.87   Accept                        
  17                         Residence address                                                                                                                                                                                                            ✓                                                        ✓       0.5              1.5    Accept                        
  18                         Work address                                                                                                                                                                                                                                                                          ✓       --0.25           1.12   Refuse                        
  19                         Insurance type^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                                                                                 ✓       1                2      Accept                        
  20                         Contact number^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                                                                          ✓      ✓       0.75             1.87   Accept                        
  21                         Email address                                                                                                                                                                                                                                                                  ✓              --0.25           1.12   Refuse                        
  22                         Family physician                                                                                                                                                                                                                                                               ✓              0                1.37   Refuse                        
  23                         Occupation status                                                                                                                                                                                                                                                              ✓      ✓       0.25             1.62   Accept                        
  Presentation information   24                                                                                                                                          Exposure date and time^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^            ✓                                  ✓      ✓      ✓       ✓                1      2                             Accept
  25                         Admission to hospital date and time^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                   ✓       ✓                                                ✓       1                2      Accept                        
  26                         Full name of treating physician^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                                                  ✓      ✓      ✓       0.75             1.75   Accept                        
  27                         Full name of referring physician                                                                                                                                                                                                                                                      ✓       0.5              1.62   Accept                        
  28                         Pre-hospital services involved date and time                                                                                                                                                                                 ✓                                                        ✓       0.5              1.75   Accept                        
  29                         Initial place of encounter for treatment^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                             ✓                                                                                               ✓                                                 0.75             1.87   Accept                        
  30                         Initial place of encounter for treatment date and time^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                ✓                                                                0.75             1.87   Accept                        
  31                         Encounter type^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                       ✓                                                                                                                                  ✓      ✓       1                2      Accept                        
  32                         Source of referral                                                                                                                          ✓                                                                                        ✓                                  ✓             ✓       0.5              1.75   Accept                        
  Discharge information      33                                                                                                                                          Discharge date and time^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^           ✓                                                        ✓                1      2                             Accept
  34                         Destination                                                                                                                                                                                                                  ✓                                                        ✓       0.25             1.62   Accept                        
  35                         Transfer to service (transfer to unit, transfer to ICU, transfer to poisoning ICU)^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                    ✓                                                        ✓       1                2      Accept                        
  36                         Hospitalization duration^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                                                                ✓      ✓       1                2      Accept                        
  37                         Outcome^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                                               ✓                                                 ✓      ✓       1                2      Accept                        
  38                         Date of future follow-ups^[a](#table-fn2-2055207619897155){ref-type="table-fn"}^                                                                                                                                             ✓                                                                0.75             1.87   Accept                        

CVR: content validity ratio; HATS: Hunter Area Toxicology Service; ICU: Intensive Care Unit; INTOX: International Toxicology; NPDS: National Poison Data System; NPIC: National Poisons Information Centers; ToxIC: Toxicology Investigators Consortium.

^a^Essential data element.

###### 

Clinical minimum data set (MDS) for drug poisoning registry system.

![](10.1177_2055207619897155-table3)

  Group                     Number                                                                                           Minimum data set                                                            ToxIC   HATS   Northern Ireland registry   NPDS   NPIC   INTOX   Medical record   CVR    Numerical mean of judgments   Accept or refuse
  ------------------------- ------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------- ------- ------ --------------------------- ------ ------ ------- ---------------- ------ ----------------------------- ------------------
  Diagnostic information    1                                                                                                Primary diagnosis^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^            ✓                                                        ✓                1      2                             Accept
  2                         Secondary diagnosis^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                   ✓                                                        ✓       1                2      Accept                        
  3                         Psychiatric diagnosis^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                 ✓                                                        ✓       0.75             1.87   Accept                        
  Exposure information      4                                                                                                Drug name^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^            ✓       ✓      ✓                           ✓      ✓      ✓       ✓                1      2                             Accept
  5                         Drug dose^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                             ✓       ✓      ✓                           ✓             ✓       1                2      Accept                        
  6                         Number or amount of drug^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                  ✓                                                                           ✓       ✓      ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  7                         Route of exposure^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                     ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  8                         Product type^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                          ✓                                                 ✓              0.75             1.87   Accept                        
  9                         Drug class                                                                                       ✓                                                                                                                                            0.25             1.62   Accept                        
  10                        Place of exposure^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                             ✓      ✓                           ✓      ✓              1                2      Accept                        
  11                        Reason of exposure^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                        ✓                                                                                          ✓                           ✓      ✓      ✓       1                2      Accept                        
  12                        Chemical formula of drug                                                                                                                                                                                                ✓      ✓              --0.5            1      Refuse                        
  13                        Type of exposure^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                     ✓                           ✓      ✓              1                2      Accept                        
  14                        Duration of exposure^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                 ✓                           ✓      ✓      ✓       1                2      Accept                        
  15                        Risk of poisoning^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                                                ✓      ✓              0.75             1.87   Accept                        
  16                        Drug colour                                                                                                                                                                                                                    ✓              0                1.25   Refuse                        
  17                        Drug constituent units                                                                                                                                                                      ✓                                  ✓              --0.25           1.12   Refuse                        
  18                        Drug country of origin                                                                                                                                                                                                         ✓              --0.25           1.37   Refuse                        
  19                        Drug legal category                                                                                                                                                                                                            ✓              --0.25           1.25   Refuse                        
  20                        Drug form                                                                                                                                                                                                                      ✓      ✓       0                1.5    Accept                        
  21                        Drug hazards and contraindications                                                                                                                                                                                      ✓      ✓              0.25             1.37   Refuse                        
  22                        Use of other substances and medications^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                                 ✓      ✓       1                2      Accept                        
  23                        Drug provided place                                                                                                                                                                                                            ✓      ✓       --0.75           1.25   Refuse                        
  Medical history           24                                                                                               Allergies^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^            ✓       ✓                                  ✓             ✓       ✓                1      2                             Accept
  25                        Cerebrovascular diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                  ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  26                        Cardiovascular diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                   ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  27                        Lung diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                             ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  28                        liver diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                            ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  29                        Renal diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                            ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  30                        Blood diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                            ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  31                        Musculoskeletal diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                  ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  32                        Gastrointestinal diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                 ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  33                        Skin diseases                                                                                    ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.5              1.75   Accept                        
  34                        Psychiatric diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                      ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  35                        Metabolic diseases^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                        ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  36                        History of alcohol consumption^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^            ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  37                        History of poisoning^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                      ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  38                        History of suicide^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                        ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  39                        Currently medication use^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                  ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  40                        Provided therapeutic procedures by EMS^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^    ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  Clinical findings         41                                                                                               General appearance^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^   ✓       ✓                                  ✓      ✓      ✓       ✓                0.75   1.75                          Accept
  42                        Serial measurements of pulse^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^              ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  43                        Serial measurements of body temperature^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^   ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  44                        Serial measurements of blood pressure^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^     ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  45                        Serial measurements of respiratory rate^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^   ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  46                        Serial measurements of consciousness^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^      ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  47                        Serotonin syndrome signs                                                                         ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.5              1.75   Accept                        
  48                        General symptoms of poisoning^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^             ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  49                        Cardiovascular symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                   ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.75   Accept                        
  50                        Lung symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                             ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  51                        Nervous system symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                   ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  52                        Metabolic symptoms                                                                               ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.5              1.75   Accept                        
  53                        Gastrointestinal/liver symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^           ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  54                        Blood symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                            ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  55                        Renal symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                            ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  56                        Musculoskeletal symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                  ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  57                        skin symptoms                                                                                    ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.5              1.75   Accept                        
  58                        Psychiatric symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                      ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  59                        Duration of symptoms^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                      ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  60                        Toxidrome^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                 ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  Diagnostic intervention   61                                                                                               CBC^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                          ✓                                         ✓              ✓                1      2                             Accept
  62                        BUN^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                   ✓                                          ✓             ✓       1                2      Accept                        
  63                        Cr^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                    ✓                                          ✓             ✓       1                2      Accept                        
  64                        Na^a^                                                                                                                                                                        ✓                                          ✓             ✓       1                2      Accept                        
  65                        K^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                     ✓                                          ✓             ✓       1                2      Accept                        
  66                        BS^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                    ✓                                          ✓             ✓       1                2      Accept                        
  67                        VBG^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                   ✓                                          ✓             ✓       1                2      Accept                        
  68                        AST^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                   ✓                                          ✓             ✓       1                2      Accept                        
  69                        ALT^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                   ✓                                          ✓             ✓       1                2      Accept                        
  70                        ALP^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                   ✓                                          ✓             ✓       0.75             1.75   Accept                        
  71                        PT^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                    ✓                                          ✓             ✓       1                2      Accept                        
  72                        PTT^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                   ✓                                          ✓             ✓       1                2      Accept                        
  73                        INR^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                                   ✓                                          ✓             ✓       1                2      Accept                        
  74                        U/A toxicology^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                        ✓                                          ✓             ✓       1                2      Accept                        
  75                        Serum level of acetaminophen                                                                                                                                                 ✓                                          ✓             ✓       0.25             1.62   Accept                        
  76                        Serum level of salicylate                                                                                                                                                    ✓                                          ✓             ✓       0.25             1.62   Accept                        
  77                        Serum level of sodium valproate                                                                                                                                              ✓                                          ✓             ✓       0.25             1.62   Accept                        
  78                        Serum level of lithium                                                                                                                                                       ✓                                          ✓             ✓       0.25             1.62   Accept                        
  79                        Serum level of iron                                                                                                                                                          ✓                                          ✓             ✓       0.25             1.62   Accept                        
  80                        Serum level of digoxin                                                                                                                                                       ✓                                          ✓             ✓       0.25             1.62   Accept                        
  81                        Electrocardiogram^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                                                                                                     ✓                                          ✓             ✓       1                2      Accept                        
  82                        Consult                                                                                                                                                                      ✓                                          ✓             ✓       0.5              1.5    Accept                        
  Treatment information     83                                                                                               Antidote ^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^            ✓       ✓                                  ✓      ✓      ✓       ✓                1      2                             Accept
  84                        Chelating agent^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                           ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.75             1.87   Accept                        
  85                        Decontamination technique^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                 ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  86                        Pharmacotherapy^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                           ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        
  87                        Non-pharmacotherapy                                                                              ✓                                                                           ✓              ✓                           ✓      ✓      ✓       0.25             1.62   Accept                        
  88                        Elimination technique^[a](#table-fn4-2055207619897155){ref-type="table-fn"}^                     ✓                                                                           ✓              ✓                           ✓      ✓      ✓       1                2      Accept                        

AST: Aspartate Aminotransferase; ALT: Alanine Aminotransferase; ALP: Alkaline Phosphatase; Bs: Blood Sugar; BUN: Blood Urea Nitrogen; CBC: Complete Blood Count; Cr: Creatinine; CVR: content validity ratio; EMS: Emergency Service; HATS: Hunter Area Toxicology Service; INR: International Normalized Ratio; INTOX: International Toxicology; NPDS: National Poison Data System; NPIC: National Poisons Information Centers; PT: Prothrombin Time; PTT: Partial Thromboplastin Time; ToxIC: Toxicology Investigators Consortium; U/A: Urine Analysis; VBG: Venous Blood Gases.

^a^Essential data element.

Final version of MDS development {#sec8-2055207619897155}
--------------------------------

Out of the total 126 data elements, 13 were refused (6 administrative and 7 clinical data elements) because the value of CVR was less than 0 and the mean of judgments was less than 1.5. Six refused data elements in the administrative part were ethnicity, race, country of birth, work address, email address and family physician. Seven refused data elements in the clinical part were chemical formula of drug, drug colour, drug constituent units, drug country of origin, drug legal category, drug hazards and contraindications, and drug provided place.

Of the 113 remaining data elements 88 were determined as essential and starred in the registry system that must be filled (21 administrative and 67 clinical data elements), and 25 were determined as usual items in the registry system that could be filled.

Discussion {#sec9-2055207619897155}
==========

This study showed that, despite the prevalence of poisoning in Iran, there is no registry system in this specific field, particularly in the drug poisoning area. Based on the study findings, the MDS for a drug poisoning registry system is divided into an administrative part with demographic information, presentation information and discharge information sections, and a clinical part with diagnostic information, exposure information, medical history, clinical findings, diagnostic intervention and treatment information sections. These results are consistent with the other study that determined the MDS for poisoning with acidic and alkaline substances information management system.^[@bibr22-2055207619897155]^

Considering the importance of the poisoning issue and the high prevalence of poisoning, other countries in the world have started to set up service centres in the area of poisoning; thus, they provide specialised information to the public and medical staff. In these poison control centres, toxicological information, counselling services for the management of people with poisoning, providing analytical laboratory services, training and research for the prevention and treatment of poisoning is provided.^[@bibr23-2055207619897155]^ The World Health Organization has introduced software called the INTOX Data Management System, specifically designed for poison control centres.^[@bibr14-2055207619897155]^ This software provides the ability to create integrity in various databases and facilitates tracking of contacts, storing information and statistical analyses. The information contained in this software includes demographic information, the main reason for referring, how to refer, exposure information, exposure reason (intentionally and unintentionally), the type of toxic substance, clinical symptoms, treatment information and clinical outcomes.^[@bibr14-2055207619897155]^ Sex, age, ethnic origin, marital status, pregnant status, lactating status, height, weight and occupation are considered as demographic data elements in this software. These elements are almost consistent with the demographic information in the present study; however, ethnic origin element was refused because it attained a CVR value less than 0 and the mean of judgments less than 1.5. Product colour, product constituent units, product country of origin, product legal category, product hazards and contraindications clinical data elements that collected in INTOX Data Management System, were refused in the present study.

The ToxIC registry was established by the American College of Medical Toxicology for surveillance and research purposes.^[@bibr12-2055207619897155]^ This registry collected the following MDS: demographic information, exposure information, agent information, clinical syndromes, symptoms and signs information, and treatment information.^[@bibr12-2055207619897155]^ The demographic and exposure information of this registry is more limited than the present study. In the ToxIC registry only the name of the institution, age, sex and patient code of the demographic information is collected. Almost other collected information is consistent with the results of the present study.

The HATS in New South Wales, Australia was developed as a database for gathering data about poisoning cases.^[@bibr13-2055207619897155]^ This database collected the following MDS: demographic information, exposure information, presentation information, past history, clinical examination, psychiatric consultation, treatment information, outcome, discharge and follow-up information.^[@bibr13-2055207619897155]^ The demographic information in this data base includes medical record number, name of patient, date of birth, country of birth, ethnic origin, marital status, height, weight, employment status and address. The demographic information in the present study is wider, but the element of country of birth and ethnic origin were refused from the MDS because they achieved a CVR value less than 0 and mean of judgments less than 1.5. Other main collected information is consistent with the drug poisoning MDS in the present study.

Similar to the other countries, the most common cause of poisoning in Iran is the consumption of drugs in excess of the amount for treatment.^[@bibr8-2055207619897155],[@bibr24-2055207619897155]^ This can be because of the accessibility of pharmaceutical drugs in Iran. For example, the availability of benzodiazapines without prescription in some cases is a major cause of using them for suicide commitment.^[@bibr25-2055207619897155]^ Using a drug registry system that collects standardised data to identify the causes and control this type of poisoning is necessary.

The development of a MDS is the most basic task in the data collection of a disease registry system for guiding and supporting healthcare providers and using the data for administrative and research goals. Data sharing and interoperability can improve by using a proper MDS.^[@bibr26-2055207619897155],[@bibr27-2055207619897155]^ Therefore, the development of MDS by standardization of data element is essential.

In this study, the sample size of expert panel involved eight experts of health information management departments of Tehran and Kerman Universities of Medical Sciences, and eight clinical toxicology experts working in Loghman Hakim, Baharloo and Afzalipour Hospitals. However, these experts were selected from two provinces of Iran; the addition of more expert participation from other medical universities across the country is suggested to yield higher validity for national MDS development.

Conclusion {#sec10-2055207619897155}
==========

A registry system for drug poisoning data is needed which has two main components that are administrative and clinical with three and six subcomponents respectively. Collecting these data elements as accurate epidemiological data about drug poisoning is critical for helping policy makers and healthcare providers to prevent, control and manage this condition.
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